Cycloheximide
(Synonyms: Naramycin A; Actidione; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide) 目录号 : GC17198环己酰亚胺是一种抗生素,它在翻译水平上抑制蛋白质合成,仅对真核细胞的细胞质(80s)核糖体起作用。
Cas No.:66-81-9
Sample solution is provided at 25 µL, 10mM.
- Adv Sci (2023): 2303113.PMID:37877615
- Oncogene (2023): 1-13.PMID:38040806
- Cell Signal (2024):111064.PMID:38266744
- Drug Resist Update (2024):101063.PMID:38335844
- J Mol Endocrinol 72.3 (2024).PMID:38261314
- J Pharm Anal 14.1 (2024):69-85.PMID:38352950
- J Biol Chem (2024):107139.PMID:38447792
- J Biol Chem 300.4 (2024).PMID:38447792
- Aging 16.8 (2024):6773-6795.PMID:38643468
- J Clin Immunol 44.6 (2024):1-14.PMID:38773005
- J Nutr Biochem (2024):109678.PMID:38844080
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Cell Mol Life Sci 81.1 (2024):292.PMID:38976080
- Acta Pharmacol Sin (2024):1-14.PMID:38992120
- J Exp Clin Canc Res 43.1 (2024):208.PMID:39061061
- Ecotox Environ Safe 283 (2024):116816.PMID:39096685
- Am J Resp Cell Mol (2024).PMID:39265182
- Lipids Health Dis 23.1 (2024):381.PMID:39558335
Cycloheximide is an antibiotic that inhibits protein synthesis at the translation level, acting exclusively on cytoplasmic (80s) ribosomes of eukaryotes. Cycloheximide affected all the energy-dependent stages in the protein-synthesizing process. However, the initiation seems the most sensitive. Cycloheximide also affects respiration, ion uptake, amino acid biosynthesis, and DNA and RNA synthesis, effects that are probably secondary to its effect on protein synthesis.[1]
In vitro study indicated that Cycloheximide at 1 μM inhibited [3H]leucine incorporation into both cellular and secreted proteins by at least 86%, without having deleterious effects on membrane integrity as indicated by trypan blue uptake and lactate dehydrogenase release. Larger size class polysomes (7+) were increased by Cycloheximide treatment and remained increased during recovery. [2]
In vivo analysis indicated that Cycloheximide produced initial hyperactivity. This initial hyperactivity was apparent within 3 minutes after injection of the Cycloheximide. Cycloheximide affects activity by acting on the brain, and this is unrelated to its inhibition of protein synthesis. In addition, Cycloheximide’s effects on activity did not appear to be responsible for its amnesic action. However, Cycloheximide might have some other property, unrelated to inhibition of cerebral protein synthesis, that is responsible for its amnesic effect.[3]
References:
[1]. Marcos R, et al. Effect of Cycloheximide on different stages of Drosophila melanogaster. Toxicol Lett. 1982 Sep;13(1-2):105-12.
[2].Helinek TG, et al. Initial inhibition and recovery of protein synthesis in cycloheximide-treated hepatocytes. Biochem Pharmacol. 1982 Apr 1;31(7):1219-25.
[3]. Segal DS, et al. Cycloheximide: its effects on activity are dissociable from its effects on memory. Science. 1971 Apr 2;172(3978):82-4.
环己酰亚胺是一种抗生素,它在翻译水平上抑制蛋白质合成,仅对真核细胞的细胞质(80s)核糖体起作用。环己酰亚胺影响蛋白质合成过程中所有依赖能量的阶段,但启动似乎最为敏感。环己酰亚胺还会影响呼吸、离子摄取、氨基酸生物合成以及DNA和RNA合成等效应,这些效应可能是由其对蛋白质合成的影响所致。[1]
体外研究表明,1微米的环丝氨酸甲基转移酶(Cycloheximide)至少抑制了86%的[3H]亮氨酸蛋白质合成,而不会对细胞膜完整性产生有害影响,这是通过尝试蓝染色和乳酸脱氢酶释放来确定的。大型多聚体(7+)在环丝氨酸甲基转移酶处理后增加,并在恢复期间保持增加。
在体内分析表明,环丝氨酸霉素会产生初始的过度活跃。这种初始的过度活跃在注射环丝氨酸霉素后3分钟内就能显现出来。环丝氨酸霉素通过作用于大脑影响活动,而这与其抑制蛋白质合成无关。此外,环丝氨酸霉素对活动的影响似乎不是导致其遗忘作用的原因。然而,环丝氨酸霉素可能具有一些其他性质,与抑制大脑蛋白质合成无关,这些性质可能是导致其遗忘效应的原因。[3]
Cell experiment [1]: | |
Cell lines |
Hepatocyte |
Preparation Method |
Hepatocyte suspensions(2 x 106 cells/ml) were incubated in polycarbonate flasks, at 37℃, under a constant stream of 95% O2- 5% CO2, with constant shaking (72 cycles/min), for 15 min before addition of cycloheximide. |
Reaction Conditions |
Hepatocytes were treated with a range of concentrations of cycloheximide from1 x 10-7 to 5 x 10-3 M). |
Applications |
Low, non-toxic dose of cycloheximide provides reasonable assurance that protein synthetic ability could be perturbed without causing undue alterations in other biochemical functions of the cell. A nontoxic dose of cycloheximide (1 μM) inhibited termination to a greater extent than other translational steps. This effect showed a dose-dependent manner. |
Animal experiment [2]: | |
Animal models |
Male Sprague-Dawley rats,weighing between 160-230 g |
Preparation Method |
Mice were maintained on Purina Chow and water ad libitum. Food was withdrawn from the animals the night before they were given 14C-ANIT, Cycloheximide was injected 1/2, 1, 2, 4, 8 or 24 h before ANIT administration. |
Dosage form |
2 mg/kg |
Applications |
Cycloheximide is capable of protecting against ANIT-induced hyperbilirubinemia even if given 24 h before ANIT. It became apparent that cycloheximide treatment resulted in substantially reduced amounts of ANIT-equivalents in all tissues examined, even if cycloheximide was given 24 h before ANIT. |
References: [1]. Helinek TG, et al. Initial inhibition and recovery of protein synthesis in cycloheximide-treated hepatocytes. Biochem Pharmacol. 1982 Apr 1;31(7):1219-25. [2]. Lock S, et al. Effect of cycloheximide on the distribution of alpha -naphthylisothiocyanate in rats. Exp Mol Pathol. 1974 Oct;21(2):237-45. |
Cas No. | 66-81-9 | SDF | |
别名 | Naramycin A; Actidione; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide | ||
化学名 | 4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione | ||
Canonical SMILES | CC1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C | ||
分子式 | C15H23NO4 | 分子量 | 281.4 |
溶解度 | ≥ 100 mg/mL (355.87 mM) in DMSO, ≥ 57.6 mg/mL in EtOH, ≥ 14.05 mg/mL in Water with ultrasonic and warming | 储存条件 | 4°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.5537 mL | 17.7683 mL | 35.5366 mL |
5 mM | 0.7107 mL | 3.5537 mL | 7.1073 mL |
10 mM | 0.3554 mL | 1.7768 mL | 3.5537 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
-
Related Biological Data
(F-G)Western blotting and quantification analyses of the effect of GPRC5A overexpression on LAMTOR1 stability in TNBC cells.
TNBC cells incubated with CHX (GlpBio, USA) (50ug/ml for SUM159PT, 25ug/mg for MDA-MB-231) or MG132 (10uM) at the indicated time points.
Drug Resistance Updates (2024): 101063. PMID: 38335844 IF: 24.3008 -
Related Biological Data
BAG3 induces PARP1-K249 ubiquitination by WWP2. (C) NC or shBAG3 HUVECs underwent subsequent treatment with CHX for different lengths of time, and the degradation speed (slope) of PARP1 was determined by immunoblot.
The proteasome suppressor MG132 (A2585; 20μM in DMSO) and cycloheximide (CHX, GC17198; 100μM in DMSO) were from GlpBio (USA).
Redox Biology (2022): 102238. PMID: 35066290 IF: 11.79 -
Related Biological Data
Epimedin B (EB) improves tyrosinase (TYR) and TYR-related protein 1 (TYRP1) stability by affecting the ubiquitin-proteasome degradation pathway. (A) The protein expression levels of TYR, TYRP1, and dopachrome tautomerase (DCT) (cycloheximide (CHX): 50 mg/mL; monobenzone: 30 mM; EB: 100 mM for 0, 6, 12, and 24 h), and statistics for TYR, TYRP1, and DCT expression.
Cells were treated with CHX (GlpBio, USA) (25ug/mL), which is a protein synthesis inhibitor, and cotreated with monobenzone (30uM) and EB (100uM) for 0, 6, 12, and 24 h.
J Pharm Anal, 2024, 14(1): 69-85. PMID: 38352950 IF: 8.8005 -
Related Biological Data
The result of protein half-life assay showed that overexpression of IMPDH2 significantly extended the half-life of endogenous IMPDH1.
Cells transfected with the indicated plasmids were treated with CHX (100μg/ml) (GlpBio, USA) for the indicated times before collection.
Clin Transl Med 13.1 (2023): e1164. PMID: 36629054 IF: 8.5535 -
Related Biological Data
Analysis of c-Myc expression by Western blot (with β-tubulin and GAPDH as loading controls). F Western blots of c-Myc in cells treated with CHX after pretreated with MG132 for 6h.
Cells were treated with 50μg/ml cycloheximide (CHX, GC17198 from GLPBIO) for 30 min, 60 min and 90 min.
Cell Death & Disease 13.4 (2022): 1-12. PMID: 35365616 IF: 8.4685